Drug intelligence / Profile preview

Outfast

Development stage: Unknown
Lead developer: Yichang Humanwell Pharmaceutical
Administration: Oral

Overview

Outfast is an oral carbohydrate solution administered preoperatively to improve postoperative recovery. It functions by providing exogenous carbohydrates, which helps to mitigate the metabolic stress associated with prolonged fasting before surgery. This intervention aims to reduce discomfort, anxiety, insulin resistance, and catabolism, leading to earlier recovery of gastrointestinal function and a shorter hospital stay. It has been studied in diabetic patients undergoing gastrointestinal surgery and in patients undergoing daytime oral surgery.

Brand names: Outfast
Other names: outfast®

Beyond the preview

Go deeper on Outfast.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Outfast.

Explore the full profile